Physician profile
Manuel M Reyes
NPI 1891069050
$88,249.38
in general payments reported to CMS, 2019-2025
37 companies · $3,709 in 2025
The $3,709 reported for 2025 was more than what 79% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $27K · 2021: $24K · 2022: $7,928 · 2023: $5,068 · 2024: $3,402 · 2025: $3,709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,079 · Travel and Lodging: $2,475 · Consulting Fee: $2,125 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,079.33 |
| Travel and Lodging | $2,474.97 |
| Consulting Fee | $2,125.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $42,519.85 | 2019-2025 | Dragonfly Opstar, Triclip, Cardiomems |
| Edwards Lifesciences Corporation | $30,596.25 | 2020-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Cardiovascular Systems INC. | $9,037.46 | 2019-2022 | |
| Biosense Webster, INC. | $1,275.34 | 2020-2024 | Carto 3 |
| E.R. Squibb & Sons, L.L.C. | $503.30 | 2021-2025 | Eliquis, Camzyos |
| Medtronic Vascular, INC. | $410.23 | 2019-2020 | |
| Boston Scientific Corporation | $370.34 | 2024-2025 | Watchman Flx, Accolade Sr, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $325.90 | 2023-2024 | Onyx Frontier, Hawkone, Closurefast |
| Ge Healthcare | $296.47 | 2023 | Allia |
| Abiomed | $295.27 | 2019 | |
| Angiodynamics, INC. | $248.33 | 2025 | Auryon Laser System 100-120 Vac |
| Biotronik INC. | $235.06 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $198.55 | 2021-2024 | |
| Pfizer INC. | $183.07 | 2019-2024 | |
| Elutia, INC. | $166.85 | 2025 | Ecm Patch,Pouch |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Reyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.